US10022399B1ActiveUtility

Nutritional composition for providing relief from wine induced headaches

Assignee: FORCE MARK CAMPBELLPriority: May 12, 2015Filed: Mar 23, 2016Granted: Jul 17, 2018
Est. expiryMay 12, 2035(~8.8 yrs left)· nominal 20-yr term from priority
A61K 9/48A61K 31/455A61K 31/353A23L 33/40A61K 33/04A61K 31/51A61K 31/4415A23L 33/105A61K 31/355A61K 31/519A23L 33/175A61K 31/525A23L 33/16A23V 2002/00A23L 33/13A23L 33/15A23L 29/015A23L 1/302A23L 1/304A23L 1/3002A61K 36/899A61K 36/21A61K 33/24A61K 36/534A61K 36/48A61K 36/23A23L 1/3051A23L 1/296A61K 36/31
53
PatentIndex Score
1
Cited by
13
References
3
Claims

Abstract

A dietary nutritional supplement that provides relief for light to moderate wine consumers who experience headaches triggered by light to moderate wine consumption. The nutritional composition consists of at least one member selected from the group of ingredients consisting of: Molybdenum, Selenium, Vitamin B1, Vitamin B2, Vitamin B3, Vitamin B6, Folic acid, Quercetin, and Vitamin E. Alternative embodiments may include nitrogreens. The ingredients for the composition form a synergy with each other to improve metabolism of wine constituents. A method of use requires six sequential weeks of administering the composition in pill form and in predetermined quantities with predetermined amounts of wine. A survey questionnaire is given to experimental subjects to help assess the efficacy of the nutritional composition.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for using a nutritional composition for providing relief from wine-induced headaches associated with minimal to moderate wine drinking, the method comprising:
 ceasing to drink wine for a selected period of time; and
 administering a composition including a composition mixture, in the form of a capsule or tablet, having a pharmaceutically effective quantity of each of the following ingredients to ameliorate headaches caused by wine consumption wherein a cause of wine-induced headaches is sensitivity to a constituent in the wine selected from the group consisting of sulfites, histamines, phenols, prostaglandins, tyramines, and aldehydes, the composition comprising: 
 
 from about 10 mcg to about 600 mcg Molybdenum; 
 from about 10 mcg to about 600 mcg Selenium; 
 from about 0.1 mg to about 2000 mg Vitamin B1; 
 from about 0.01 mg to 400 mg Vitamin B2; 
 from about 5 mg to about 4000 mg Vitamin B3; 
 from about 1 mg to about 500 mg Vitamin B6; 
 from about 25 mcg to about 20 mg Folic acid; 
 from about 5 mg to about 1800 mg Quercetin; and 
 from about 1 IU to about 800 IU Vitamin E wherein: ceasing to drink wine for a selected period of time comprises ceasing to drink wine during a first week; and administering a composition including a composition mixture having a pharmaceutically effective quantity of each of the following ingredients to ameliorate headaches caused by wine consumption comprises: administering two capsules of a nutritional composition during a second week, the two capsules administered twice a day after meals; administering two capsules of the nutritional composition during a third week, the two capsules administered twice a day after meals; administering two capsules of the nutritional composition during a fourth week, the two capsules administered twice a day after meals; administering one capsule of the nutritional composition during a fifth week, the one capsule administered twice a day after meals; and administering one capsule of the nutritional composition during a sixth week, the one capsule administered twice a day after meals. 
 
     
     
       2. The method of  claim 1  wherein administering the composition comprises administering the composition mixture in which the Molybdenum is present in the composition mixture in a quantity of from about 100 mcg to about 200 mcg, the Selenium is present in the composition mixture in a quantity of from about 50 mcg to about 100 mcg, the Vitamin B1 is present in the composition mixture in a quantity of from about 1 mg to about 10 mg, the Vitamin B2 is present in the composition mixture in a quantity of from about 1 mg to about 5 mg, the Vitamin B3 is present in the composition mixture in a quantity of from about 10 mg to about 100 mg, the Vitamin B6 is present in the composition mixture in a quantity of from about 5 mg to about 50 mg, the Folic acid is present in the composition mixture in a quantity of from about 100 mcg to about 600 mcg, the Quercetin is present in the composition mixture in a quantity of from about 50 mg to about 100 mg and the Vitamin E is present in the composition mixture in a quantity of from about 45 IU to about 55 IU. 
     
     
       3. The method of  claim 1  wherein administering the composition comprises administering the composition mixture including nitrogreen.

Join the waitlist — get patent alerts

Track US10022399B1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.